Complexity of electrocortical activity as potential biomarker in untreated Parkinson's disease

被引:12
|
作者
Mostile, Giovanni [1 ]
Giuliano, Loretta [1 ]
Dibilio, Valeria [1 ]
Luca, Antonina [1 ]
Cicero, Calogero Edoardo [1 ]
Sofia, Vito [1 ]
Nicoletti, Alessandra [1 ]
Zappia, Mario [1 ]
机构
[1] Univ Catania, Dipartimento Sci Med Chirurg & Tecnol Avanzate GF, Via Santa Sofia 78, I-95123 Catania, Italy
关键词
Untreated Parkinson's disease; Electrocortical complexity; Power law exponent; Fronto-temporal electrocortical activity; Biomarker; LONG-RANGE CORRELATIONS; SUBTHALAMIC NUCLEUS; FRACTAL DYNAMICS; STRIDE INTERVAL; PHYSIOLOGY; DOPAMINE; BRAIN; STABILITY; INSIGHTS; BEHAVIOR;
D O I
10.1007/s00702-018-1961-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
In Parkinson's disease (PD), the identification of instrumental biomarkers is crucial to evaluate disease susceptibility and motor stage. We evaluated self-similarity of electrocortical activity as expression of brain signal complexity in untreated PD, to investigate its possible role as a neurophysiological biomarker. We analyzed the data of 34 untreated PD subjects and 18 group-matched controls who underwent standardized electroencephalography. A Welch's periodogram was applied to site-specific electroencephalographic signal epochs. To investigate self-similarity of electrocortical activity, the power law exponent was computed for each selected coordinate. In both PD subjects and controls, values at each coordinate increased with an antero-posterior gradient, changing from values around one in fronto-temporal sites to values around two among parieto-occipital sites. PD subjects presented overall lower values among different sites compared to controls, with significant differences for the left fronto-temporal sites. Our findings suggest an increased level of fronto-temporal neuronal organization in untreated PD. We hypothesize a possible role of as a neurophysiological biomarker for early untreated PD.
引用
收藏
页码:167 / 172
页数:6
相关论文
共 50 条
  • [41] An auditory biomarker for Parkinson's disease?
    De Keyser, K.
    Bockstael, A.
    Botteldooren, D.
    Talsma, D.
    De Letter, M.
    Santens, P.
    MOVEMENT DISORDERS, 2017, 32
  • [42] A colonic biomarker of Parkinson's disease?
    Olanow, C. Warren
    MOVEMENT DISORDERS, 2012, 27 (06) : 674 - 676
  • [43] Biomarker of Neuroinflammation in Parkinson's Disease
    Liu, Tsai-Wei
    Chen, Chiung-Mei
    Chang, Kuo-Hsuan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (08)
  • [44] Olfaction as a biomarker in Parkinson's disease
    Morley, James F.
    Duda, John E.
    BIOMARKERS IN MEDICINE, 2010, 4 (05) : 661 - 670
  • [45] AN OCULAR BIOMARKER OF PARKINSON'S DISEASE
    Misra, Stuti
    Kersten, Hannah
    Roxburgh, Richard
    Danesh-Meyer, Helen
    McGhee, Charles
    CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2015, 43 : 47 - 48
  • [46] Biomarker promise for Parkinson's disease
    不详
    LANCET NEUROLOGY, 2010, 9 (12): : 1139 - 1139
  • [47] A new biomarker for Parkinson's disease?
    Williams-Gray, Caroline H.
    MOVEMENT DISORDERS, 2016, 31 (01) : 42 - 42
  • [48] Dissociation of electrocortical and electromyographic measures of movement initiation in Parkinson's disease
    Praamstra, P
    Plat, FM
    Stegeman, DF
    Horstink, MWIM
    INTERNATIONAL JOURNAL OF PSYCHOPHYSIOLOGY, 1999, 33 (01) : 83 - 83
  • [49] Genetic complexity and Parkinson's disease
    Gasser, T
    MullerMyhsok, B
    Wszolek, ZK
    Durr, A
    Vaughan, JR
    Bonifati, V
    Meco, G
    Bereznai, B
    Oehlmann, R
    Agid, Y
    Brice, A
    Wood, N
    SCIENCE, 1997, 277 (5324) : 388 - 389
  • [50] MYELIN WATER IMAGING: POTENTIAL WHITE MATTER BIOMARKER IN PARKINSON'S DISEASE
    Septian, H.
    Lee, W.
    Oh, J.
    Shih, Y. C.
    Lee, K. J.
    Lee, J.
    Xu, Z.
    Tan, L.
    Tan, E. K.
    Chan, L. L.
    PARKINSONISM & RELATED DISORDERS, 2020, 79 : E10 - E10